Sign In
Buy BHV
$12.81
-0.0750 (-0.582%)
At Close: Jul 31, 2026
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
02:23pm, Tuesday, 17'th Dec 2024
On Monday, Biohaven Ltd. BHVN revealed clinical and regulatory milestones across its proprietary Molecular Degrader of Extracellular Proteins (MoDE) platform and its glutamate modulation and ion chann
Reported expanded safety results from BHV-7000 Phase 1 multiple ascending dose studies, including the once-daily extended-release formulation being evaluated in ongoing Phase 2 and 3 clinical studies
Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
04:05pm, Tuesday, 12'th Nov 2024
Cash, cash equivalents, marketable securities and restricted cash as of October 2, 2024 totaled approximately $642 million Achieved positive topline trial results from pivotal trial with troriluzole i
Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
07:30am, Monday, 30'th Sep 2024
Biohaven initiated a pivotal Phase 2 trial evaluating BHV-2100 in the acute treatment of migraine BHV-2100 is a potential first-in-class, potent, orally administered Transient Receptor Potential Melas
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
04:05pm, Thursday, 08'th Aug 2024
Cash, cash equivalents, marketable securities and restricted cash totaled approximately $440 million on June 30, 2024 Biohaven's Molecular Degrader of Extracellular Proteins (MoDE™) platform advanc
Reports new positive interim data from the ongoing Phase 1 study of BHV-1300, Biohaven's lead investigational drug from its Molecular Degrader of Extracellular Proteins (MoDE™) platform BHV-1300 de
Biohaven: Promising Pipeline With Troriluzole, Taldefgrobep Alfa, And BHV-7000 Leading The Charge
03:10am, Saturday, 18'th May 2024
Biohaven Ltd. is a spinout of Biohaven Pharmaceutical, focusing on developing drugs in the life sciences field. BHVN has three Phase 3 drug candidates: troriluzole for OCD, taldefgrobep alfa for SMA,
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
04:30pm, Friday, 01'st Mar 2024
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: Declaration- 3/1/2024 Ex-Date- 3/14/2024 Recor
BlackRock Announces Withdrawal of Municipal Closed-End Fund Merger Proposals
07:00pm, Monday, 30'th Oct 2023
NEW YORK--(BUSINESS WIRE)--The Boards of Directors/Trustees of BlackRock MuniYield Michigan Quality Fund, Inc. (NYSE: MIY), BlackRock MuniYield Pennsylvania Quality Fund (NYSE: MPA), BlackRock Virgini
BlackRock Announces Board Approval of Municipal Closed-End Fund Mergers
04:30pm, Friday, 08'th Sep 2023
NEW YORK--(BUSINESS WIRE)--BlackRock Advisors, LLC announced today that the Boards of Directors/Trustees of BlackRock MuniYield Michigan Quality Fund, Inc. (NYSE: MIY), BlackRock MuniYield Pennsylvani
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
04:30pm, Monday, 01'st May 2023
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: Declaration- 5/1/2023 Ex-Date- 5/12/2023 Record- 5/15/
BlackRock to Host Municipal Closed-End Fund Update Call on April 6, 2023 at 2:00pm ET
04:30pm, Wednesday, 05'th Apr 2023
NEW YORK--(BUSINESS WIRE)--BlackRock Advisors, LLC (“BlackRock”) will host a conference call on Thursday, April 6, 2023 at 2:00pm ET featuring Sean Carney, Head of Municipal Strategy, and Phil Soc
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
05:00pm, Monday, 03'rd Apr 2023
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: Declaration- 4/3/2023 Ex-Date- 4/13/2023 Record- 4/14/
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
04:30pm, Wednesday, 01'st Mar 2023
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. BlackRock Floating Rate Income Trust (NYSE: BGT), BlackRock Floating Ra
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
04:30pm, Wednesday, 01'st Feb 2023
NEW YORK--(BUSINESS WIRE)--Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. BlackRock California Municipal Income Trust (NYSE: BFZ) increased its m
